Clinical Significance of High-Sensitivity C-Reactive Protein in Patients with Preserved Renal Function Following Percutaneous Coronary Intervention.


Journal

International heart journal
ISSN: 1349-3299
Titre abrégé: Int Heart J
Pays: Japan
ID NLM: 101244240

Informations de publication

Date de publication:
27 Sep 2019
Historique:
pubmed: 6 9 2019
medline: 12 10 2019
entrez: 6 9 2019
Statut: ppublish

Résumé

Although high-sensitivity C-reactive protein (hs-CRP) has been used to predict the risk of adverse cardiac events in patients with coronary artery disease (CAD) after percutaneous coronary interventions (PCIs), little is known about the association between hs-CRP and long-term outcomes in patients with preserved renal function.Here, we studied 1,153 patients with stable CAD and preserved renal function (estimated glomerular filtration rate: > 60 mL/minute/1.73 m

Identifiants

pubmed: 31484863
doi: 10.1536/ihj.18-683
doi:

Substances chimiques

Biomarkers 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1037-1042

Auteurs

Takashi Shimizu (T)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine.

Satoru Suwa (S)

Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital.

Tomotaka Dohi (T)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine.

Hideki Wada (H)

Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital.

Katsumi Miyauchi (K)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine.

Jun Shitara (J)

Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital.

Hirohisa Endo (H)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine.

Shinichiro Doi (S)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine.

Manabu Ogita (M)

Department of Cardiovascular Medicine, Juntendo University Shizuoka Hospital.

Takatoshi Kasai (T)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine.

Shinya Okazaki (S)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine.

Kikuo Isoda (K)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine.

Hiroyuki Daida (H)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH